Home » Topics » Regulatory » Patents

Patents
RSS

New thrombin inhibitors synthesized at Merck & Co.

July 13, 1998

Subtype-selective MMP inhibitors patented by Agouron, Syntex

July 13, 1998

Antagonists of neurotrophin activity described by Allelix for pain, epilepsy and AD

July 13, 1998

Merck's new tachykinin receptor antagonists useful for pain, inflammation, etc.

July 13, 1998

Collagenase inhibitors in the pipeline at British Biotech

July 13, 1998

Korean investigators design effective and safe agents for HBV

July 10, 1998

Novartis presents new protein kinase inhibitors for cancer, psoriasis

July 10, 1998

Dermatological agents in development at Galderma

July 10, 1998

GABA-A receptor modulators discovered by NeuroSearch

July 10, 1998

Compounds for dopaminergic disorders discovered at American Home Products

July 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...